SHANGHAI, Aug. 15, 2019 /PRNewswire/ -- Starting in
August 2019, 111, Inc. (NASDAQ: YI)
("111" or the "Company"), a leading integrated online and offline
healthcare platform, will launch "111 Insight", a video series on
the development of the healthcare industry in China.
The series is produced by 111, Inc., and will be hosted by Dr.
Gang Yu, Co-Founder and Executive Chairman, and Mr. Junling Liu, Co-Founder, Chairman and CEO. 111
Insight will focus on hot topics in the healthcare industry through
interviews with industry experts, investors, and healthcare
professionals.
The healthcare industry in China is evolving rapidly and there is
increasing global interest in China's health reform and policies. Among the
hot topics are how the internet is reshaping China's healthcare industry and pharmaceutical
delivery, how new government policies and regulation impact the
healthcare industry, how new technologies affect private health
insurance, and the opportunities and challenges facing China's aging population, etc.
The first video in series is How the Internet is Changing the
Healthcare Industry, hosted by Mr. Junling Liu, Co-Founder, Chairman and CEO of
111, Inc. with guests Ms. Angela Xu,
Vice President and CMO of Eli Lilly China, and Dr. Darren Ji, CEO of Elpiscience Biopharma,
Ltd.
Video Link:
111 IR website: http://ir.111.com.cn
Tencent video:
https://v.qq.com/x/page/t09130n33vi.html
Topics include:
- Quality of medical resources through internet-based healthcare
platforms
- Healthcare services - from healthcare delivery to
patient-focused models
- 111, Inc. - building a revolutionary healthcare service
system
The next installments in the "111 Insight" series are entering
production and will delve into the impact of technology on
healthcare in China.
Safe Harbor Statement
This press release contains forward-looking statements. These
statements constitute "forward-looking" statements within the
meaning of Section 21E of the Securities Exchange Act of 1934, as
amended, and as defined in the U.S. Private Securities Litigation
Reform Act of 1995. These forward-looking statements can be
identified by terminology such as "will," "expects," "anticipates,"
"future," "intends," "plans," "believes," "estimates," "target,"
"confident" and similar statements. Among other things, the
Business Outlook and quotations from management in this
announcement, as well as 111's strategic and operational plans,
contain forward-looking statements. 111 may also make written or
oral forward-looking statements in its periodic reports to the U.S.
Securities and Exchange Commission, in its annual report to
shareholders, in press releases and other written materials and in
oral statements made by its officers, directors or employees to
third parties. Such statements are based upon management's current
expectations and current market and operating conditions and relate
to events that involve known or unknown risks, uncertainties and
other factors, all of which are difficult to predict and many of
which are beyond the Company's control. Forward-looking statements
involve inherent risks, uncertainties and other factors that could
cause actual results to differ materially from those contained in
any such statements. Potential risks and uncertainties include, but
are not limited to, uncertainties as to the Company's ability
comply with extensive and evolving regulatory requirements, its
ability to compete effectively in the evolving PRC general health
and wellness market, its ability to manage the growth of its
business and expansion plans, its ability to achieve or maintain
profitability in the future, its ability to control the risks
associated with its pharmaceutical retail and wholesale businesses,
and the Company's ability to meet the standards necessary to
maintain listing of its ADSs on the Nasdaq Global Market, including
its ability to cure any non-compliance with Nasdaq's continued
listing criteria. Further information regarding these and other
risks, uncertainties or factors is included in the Company's
filings with the U.S. Securities and Exchange Commission. All
information provided in this press release is as of the date of
this press release, and 111 does not undertake any obligation to
update any forward-looking statement as a result of new
information, future events or otherwise, except as required under
applicable law.
About 111, Inc.
111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading
integrated online and offline healthcare platform in China. The Company provides hundreds of
millions of consumers with better access to pharmaceutical products
and medical services directly through its online retail pharmacy
and indirectly through its offline pharmacy network. 111 also
offers online medical services through its internet hospital, 1
Clinic, which provides consumers with cost-effective and convenient
online consultation and electronic prescription services. In
addition to providing direct services to consumers through its
online retail pharmacy, 111 also enables offline pharmacies to
better serve their customers. The Company's online wholesale
pharmacy, 1 Drug Mall, serves as a one-stop shop for pharmacies to
source a vast selection of pharmaceutical products. The Company's
New Retail platform, by integrating the front and back ends of the
pharmaceutical supply chain, has formed a smart supply chain, which
transforms the flow of pharmaceutical products to pharmacies and
modernizes how they serve their customers.
For more information on 111, please visit
http://ir.111.com.cn/
For more information, please contact:
111, Inc.
Ms. Monica
Mu
IR Director
ir@111.com.cn
Christensen
In China
Mr. Christian Arnell
Phone: +86-10-5900-1548
E-mail: carnell@christensenir.com
In U.S.
Ms. Linda Bergkamp
Phone: +1-480-614-3004
Email: lbergkamp@ChristensenIR.com
View original
content:http://www.prnewswire.com/news-releases/111-inc-launches-new-video-interview-series-on-chinas-healthcare-landscape-300902413.html
SOURCE 111, Inc.